论文部分内容阅读
沙利度胺是一种具有抗血管新生作用的谷氨酸衍生物。1957年作为孕妇镇吐、镇静药物上市。2006年5月因其具有抗肿瘤血管生成,免疫调节作用被美国FDA批准用于多发骨髓瘤的治疗。肺癌患者多数VEGF表达升高,促进肿瘤生长、转移。我院开展沙利度胺联合NP方案治疗晚期非小细胞肺
Thalidomide is a glutamate derivative that has anti-angiogenic effects. 1957 as a pregnant woman vomiting, sedative drug market. May 2006 because of its anti-tumor angiogenesis, immune regulation by the United States FDA approved for the treatment of multiple myeloma. Most patients with lung cancer increased VEGF expression, promote tumor growth and metastasis. Our hospital to carry out thalidomide combined with NP regimen for the treatment of advanced non-small cell lung